S-1 · primary offering
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
OPTH$2.29+2.23%
Optimi Health Corp.
Sector: Pharmaceutical PreparationsIndustry: Drug Manufacturers - Specialty & GenericCountry: CAExchange: Nasdaq
Mkt Cap:$13.11M
Float & O/S:
Inst Own:
DilutionScan read 28 of Optimi Health Corp.'s SEC filings and found 10 warrant series, 3 convertibles, 1 equity line, 2 S-1 registrations and 1 completed offering on file for OPTH. The latest dilution event on file is a registration statement on Aug 25, 2026. Analysis updated Sep 28, 2026.
Signal8 Summary
OPTH
Negative gross margin and reverse split
Snapshot
Optimi Health is a tiny psychedelic manufacturer with deeply negative unit economics. FY 2025 revenue was just $301K, but the company posted a negative gross margin of -486%, meaning it cost far more to produce its drugs than it sold them for.
What's Happening Right Now
- : Optimi completed its third commercial shipment of 5mg psilocybin capsules to Australia for treatment-resistant depression under the Authorized Prescriber Scheme.
- : The company completed its first export of naturally derived psilocybin to the United Kingdom to support a planned Phase 2 clinical trial.
- : Optimi secured naturally derived ibogaine from two sources and will commence development of finished drug products at its facility this summer.
- : Australia's Therapeutic Goods Administration updated its Authorized Prescriber framework to broaden therapist eligibility and allow treatment in non-hospital settings.
- : Optimi Health priced a $15 million public offering at $6.25 per share alongside a 1-for-30 reverse stock split and uplisting to the Nasdaq Capital Market.
Raise routes on file: effective S-1 + active equity line · latest dilution event 70 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Aug 25, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Completed
S-1 · resale registration
Issued 2026
Proposed maximum
Shares registered
- Filed
- Effective
Warrant
Issued 2023
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2023
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2023
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2024
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2024
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2024
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Unsecured Convertible Debentures due July 24, 2026 (issued July 24, 2025)
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Equity line
Issued 2026
Commitment
Sold to date
Remaining
- Agreement date
- Term ends
- Discount
Public offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your OPTH trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
